Fetal therapy for Down syndrome: an ethical exploration-Reference-Cited by-同舟云学术

Fetal therapy for Down syndrome: an ethical exploration

Published:2017-02-01 Issue:3 Volume:37 Page:222-228
ISSN:0197-3851
Container-title:Prenatal Diagnosis
language:en
Short-container-title:Prenat Diagn

Author:

de Wert Guido¹,Dondorp Wybo¹^ORCID,Bianchi Diana W.²^ORCID

Affiliation:

1. Department of Health, Ethics & Society, School for Oncology and Developmental Biology (GROW), School for Public Health and Primary Care (CAPHRI); Maastricht University; Maastricht The Netherlands

2. Mother Infant Research Institute; Tufts Medical Center and Tufts University School of Medicine; Boston MA US

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

Reference46 articles.

1. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis;Gil;Ultrasound Obstet Gynecol,2015

2. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis;Taylor-Phillips;BMJ Open,2016

3. DNA sequencing versus standard prenatal aneuploidy screening;Bianchi;N Engl J Med,2014

4. Cell-free DNA analysis for noninvasive examination of trisomy;Norton;N Engl J Med,2015

5. From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges;Bianchi;Nat Med,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Down Syndrome is Not a Curse”: parent Perspectives on the Medicalization of Down Syndrome;AJOB Empirical Bioethics;2024-08-07

2. Reproductive medicine: ethical reflections;Textbook of Obstetrics and Gynaecology;2024

3. Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies;Risk Management and Healthcare Policy;2022-11

4. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives;Frontiers in Cellular Neuroscience;2022-05-11

5. A new ethical framework to determine acceptable risks in fetal therapy trials;Prenatal Diagnosis;2022-05-06